Document is current
Any future updates will be listed below
-
Authors
Liu, Yu
Zhao, Hanxing
Yu, Jiaying
Liao, Dongsheng
Peng, Jingming
Chen, Changjin
Huang, Yeqian
Chen, Chiaoju
Li, Zhengyong
Wijaya, Wilson Adrian
Zhao, Ziyi
Chen, Zhixing
-
Funding
Funding for this research was provided by:
Sichuan Province Science and Technology Support Program (2022YFS0199)
- License Information
-
More Information
Article History
Received: 1 July 2024
Accepted: 3 September 2024
First Online: 28 September 2024
Declarations
:
: The SoniConvert® Single-cell Suspension Preparation System and the fat dissociation solution were provided by the Chengdu DosSense Biotech Co., LTD for free, and the authors declare that they have no conflicts of interest to disclose.
: The study protocol about patient was approved by the Ethics Committee of West China Hospital, Sichuan University, on October 2, 2020 (No. 2020(806)). All experimental procedures about animals used in this study were reviewed and approved by the Animal Ethics Committee of West China Hospital, Sichuan University, on October 19, 2020 (2020303A).
: We have got the consent for publication from our patient, and the copy is available.
